Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1987-4-27
|
pubmed:abstractText |
After several in vitro treatments of a virulent population of Leishmania major with the mutagen, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), five clones (vir-) were obtained that did not produce cutaneous lesions after subcutaneous injection of 10(6) promastigotes. All the control clones (vir+) obtained from the non-mutagenized parasite population produced progressive cutaneous lesions with as few as 10(3) parasites. Late lesions were observed occasionally after injection of 10(7) vir- parasites. These late lesions appeared to result from the selection of virulent revertants, since parasites isolated from these lesions produced progressive lesions in BALB/c mice almost as readily as the control parasites. Two vir- clones, one vir+ clone and one revertant clone were examined for survival in BALB/c macrophages in vitro. All clones were taken up by the macrophages and transformed into amastigotes. However, vir- clones failed to multiply inside the macrophages. A vir- clone was found to protect mice against a subsequent challenge with vir+ parasites.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0141-9838
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
81-92
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3562060-Agglutination,
pubmed-meshheading:3562060-Animals,
pubmed-meshheading:3562060-Leishmania tropica,
pubmed-meshheading:3562060-Leishmaniasis,
pubmed-meshheading:3562060-Macrophages,
pubmed-meshheading:3562060-Methylnitronitrosoguanidine,
pubmed-meshheading:3562060-Mice,
pubmed-meshheading:3562060-Mice, Inbred BALB C,
pubmed-meshheading:3562060-Mutation,
pubmed-meshheading:3562060-Virulence
|
pubmed:year |
1987
|
pubmed:articleTitle |
Variants with reduced virulence derived from Leishmania major after mutagen treatment.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|